Search details
1.
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast.
Mod Pathol
; 33(6): 1065-1077, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31925342
2.
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer.
Pharmacogenomics J
; 20(1): 19-26, 2020 02.
Article
in English
| MEDLINE | ID: mdl-30967597
3.
Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.
Int J Cancer
; 139(9): 2127-34, 2016 Nov 01.
Article
in English
| MEDLINE | ID: mdl-27381855
4.
A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen.
Breast Cancer Res Treat
; 159(1): 97-108, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27484880
5.
E-cadherin germline mutation carriers: clinical management and genetic implications.
Cancer Metastasis Rev
; 33(4): 1081-94, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25332147
6.
Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
Genes Chromosomes Cancer
; 53(5): 432-45, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24493355
7.
Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysis.
Carcinogenesis
; 35(9): 1913-9, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-25053622
8.
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.
Breast Cancer Res Treat
; 148(1): 81-90, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25253174
9.
Vitamin D receptor polymorphisms and cancer.
Adv Exp Med Biol
; 810: 69-105, 2014.
Article
in English
| MEDLINE | ID: mdl-25207361
10.
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up Study.
Cancers (Basel)
; 16(7)2024 Apr 04.
Article
in English
| MEDLINE | ID: mdl-38611089
11.
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial.
Cancer Prev Res (Phila)
; 17(6): 255-263, 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38530139
12.
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.
NPJ Breast Cancer
; 10(1): 7, 2024 Jan 18.
Article
in English
| MEDLINE | ID: mdl-38238336
13.
A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer.
Breast Cancer Res
; 15(3): R47, 2013 Jun 20.
Article
in English
| MEDLINE | ID: mdl-23786776
14.
Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.
Breast Cancer Res Treat
; 142(3): 569-78, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24241787
15.
Editorial for the Special Issue "Genetics and Genomics of Gastrointestinal Cancers: From Prevention to Treatment".
Genes (Basel)
; 14(9)2023 09 20.
Article
in English
| MEDLINE | ID: mdl-37761961
16.
Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer.
Healthcare (Basel)
; 11(16)2023 Aug 21.
Article
in English
| MEDLINE | ID: mdl-37628558
17.
Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial.
Biomedicines
; 11(6)2023 Jun 20.
Article
in English
| MEDLINE | ID: mdl-37371861
18.
Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience.
Genes (Basel)
; 14(5)2023 05 13.
Article
in English
| MEDLINE | ID: mdl-37239438
19.
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 9(5): 664-672, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-36951827
20.
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study.
J Clin Oncol
; 41(17): 3116-3121, 2023 06 10.
Article
in English
| MEDLINE | ID: mdl-36917758